Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

T Liu, S Luo, P Libby, GP Shi - Pharmacology & therapeutics, 2020 - Elsevier
The widespread coronavirus SARS-CoV-2 has already infected over 4 million people
worldwide, with a death toll over 280,000. Current treatment of COVID-19 patients relies …
被引用次数：271 相关文章
[HTML] nih.gov

[HTML][HTML] Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

T Liu, S Luo, P Libby, GP Shi - Pharmacology & Therapeutics, 2020 - ncbi.nlm.nih.gov
The widespread coronavirus SARS-CoV-2 has already infected over 4 million people
worldwide, with a death toll over 280,000. Current treatment of COVID-19 patients relies …

[引用][C] Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

T Liu, S Luo, P Libby, GP Shi - Pharmacology & Therapeutics, 2020 - cir.nii.ac.jp
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

T Liu, S Luo, P Libby, GP Shi - Pharmacology & …, 2020 - pubmed.ncbi.nlm.nih.gov
The widespread coronavirus SARS-CoV-2 has already infected over 4 million people
worldwide, with a death toll over 280,000. Current treatment of COVID-19 patients relies …

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients.

T Liu, S Luo, P Libby, GP Shi - Pharmacology & Therapeutics, 2020 - europepmc.org
The widespread coronavirus SARS-CoV-2 has already infected over 4 million people
worldwide, with a death toll over 280,000. Current treatment of COVID-19 patients relies …

Cathepsin L-selective inhibitors: a potentially promising treatment for COVID-19 patients.

T Liu, S Luo, P Libby, GP Shi - 2020 - cabidigitallibrary.org
The widespread coronavirus SARS-CoV-2 has already infected over 4 million people
worldwide, with a death toll over 280,000. Current treatment of COVID-19 patients relies …

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

T Liu, S Luo, P Libby, GP Shi - Pharmacology & …, 2020 - pubmed.ncbi.nlm.nih.gov
The widespread coronavirus SARS-CoV-2 has already infected over 4 million people
worldwide, with a death toll over 280,000. Current treatment of COVID-19 patients relies …